- Disease: Acute COVID-19, Avian Influenza, Influenza
- Study type: Randomised Clinical Trial, Adaptive Platform Trial, Treatment
- Objective: To evaluate treatments for community acquired pneumonia in the hospital setting
- Number of participants enrolled: 8442
- Study enrolling from
Study Data
- Adults (18-64 years)
- Hospital
- Intensive care unit
- SARS-CoV-2
- Influenza virus
- Influenza A(H5N1) virus
- Acute COVID-19
- Influenza
- Avian Influenza
- Pharmacological intervention
- Immunomodulator
- Corticosteroid
- Baloxavir
- Oseltamivir
External Links
Other information
Funders/Sponsors:
- Horizon 2020
The information was provided with the aid of the study investigators
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to